FFRangio System vs EchoConfidence (USA)
AI Verdict
Choose FFRangio System if…
Choose the FFRangio System if your cath lab requires real-time, non-invasive physiological guidance to optimize percutaneous coronary intervention (PCI) decisions. This tool is ideal for interventional cardiologists seeking to quickly assess multi-vessel coronary artery disease severity and confirm treatment efficacy without the need for pressure wires or vasoactive drugs. It excels in providing detailed 3D FFR insights and lesion impact assessments directly from angiography.
View FFRangio System →Choose EchoConfidence (USA) if…
Choose EchoConfidence if your cardiology department aims to enhance the efficiency and accuracy of transthoracic echocardiogram analysis and reporting. This AI-powered solution is best suited for echocardiography labs looking to automate cardiac structure segmentation, functional measurements, and report generation, thereby streamlining diagnostic workflows. It provides robust support for cardiologists, critical care, and emergency medicine physicians in interpreting echo images and producing comprehensive reports.
View EchoConfidence (USA) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FFRangio System | EchoConfidence (USA) |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Unknown |
| Deployment | SaaS, on-prem, hybrid | On-premise within the hospital's existing DICOM, PACS, and RIS infrastructure. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FFRangio System | EchoConfidence (USA) |
|---|---|---|
| Name | FFRangio System | EchoConfidence (USA) |
| Company | CathWorks | Mycardium AI Limited |
| Primary Use Case | Delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease. | AI-powered Software as a Medical Device (SaMD) for analyzing transthoracic echocardiogram images, automating measurements, and assisting in report generation to enhance cardiac diagnostics and streamline workflows. |
| Key AI Functionality | Artificial intelligence aids in quick angiogram analysis; provides real-time FFRangio values at every point on the coronary tree; simulated pullback curve differentiates functional patterns of CAD; Lesion Impact feature to assess residual ischemia. | AI-powered transthoracic echocardiogram analysis; automatic view classification; segmentation of cardiac structures (ventricles, atria, walls, great vessels); measures of cardiac function; Doppler assessments; human-in-the-loop AI capabilities. |
| Specialties | Cardiology | Cardiology, Critical Care, Emergency Medicine |
Videos
Demos, reviews, and walkthroughs featuring FFRangio System and EchoConfidence (USA).